AHL Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$7.06M Sell
50,547
-15,442
-23% -$2.15M 0.11% 352
2017
Q3
$8.58M Buy
65,989
+23,305
+55% +$3.09M 0.15% 222
2017
Q2
$5.65M Buy
42,684
+16,606
+64% +$2.12M 0.12% 304
2017
Q1
$3.25M Buy
26,078
+8,625
+49% +$1.03M 0.07% 486
2016
Q4
$2.01M Buy
17,453
+4,740
+37% +$548K 0.06% 507
2016
Q3
$1.5M Buy
12,713
+4,266
+51% +$518K 0.06% 472
2016
Q2
$1.02M Buy
8,447
+1,431
+20% +$163K 0.06% 432
2016
Q1
$760K Sell
7,016
-21,841
-76% -$2.26M 0.05% 461
2015
Q4
$2.96M Buy
28,857
+21,872
+313% +$2.2M 0.23% 152
2015
Q3
$652K Sell
6,985
-48,472
-87% -$4.69M 0.1% 279
2015
Q2
$5.41M Sell
55,457
-1,310
-2% -$131K 0.22% 144
2015
Q1
$5.71M Buy
56,767
+29,820
+111% +$3.03M 0.23% 117
2014
Q4
$2.82M Buy
26,947
+21,987
+443% +$2.32M 0.15% 263
2014
Q3
$529K Buy
+4,960
New +$514K 0.04% 469

Other funds holding JNJ

AHL Partners's JNJ Position: Q4 2017 in Review

AHL Partners reduced its Johnson & Johnson (JNJ) stake by 23% in Q4 2017, selling an estimated $2.15M and leaving 50,547 shares worth $7.06M. The position accounts for 0.11% of the portfolio, ranked #352.

AHL Partners first reported a position in JNJ in Q3 2014 and has held it in 14 quarters since. The position peaked at $8.58M in Q3 2017. 2,623 funds tracked by Wall St. Rank hold JNJ as of Q4 2017.

  • AHL Partners held 50,547 shares of Johnson & Johnson worth $7.06M as of Q4 2017.
  • AHL Partners sold 15,442 Johnson & Johnson shares in Q4 2017, an estimated $2.15M.
  • Johnson & Johnson made up 0.11% of AHL Partners's portfolio in Q4 2017, its #352 holding.
  • AHL Partners first reported a position in Johnson & Johnson in Q3 2014 and has held it in 14 quarters since.
  • AHL Partners's Johnson & Johnson position peaked at $8.58M in Q3 2017.
  • 2,623 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.